← Evidence map

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Cost-effectiveness analysis of pegfilgrastim in patients with non-small cell lung cancer receiving ramucirumab plus docetaxel in Japan.

Yu Kondo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35524869